Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BPTH Bio-Path Holdings, Inc.

美国阵亡战士纪念日休市 05-24 16:00:00 EDT

2.03

+0.02

+1.00%

盘后2.11

+0.08+3.94%

19:43 EDT

最高2.10	最低2.00	成交量7.68万
今开2.01	昨收2.01	日振幅4.98%
总市值336.22万	流通市值335.76万	总股本165.62万
成交额15.55万	换手率4.64%	流通股本165.40万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BPTH","market":"US","secType":"STK","nameCN":"Bio-Path Holdings, Inc.","latestPrice":2.03,"timestamp":1716580800000,"preClose":2.01,"halted":0,"volume":76780,"hourTrading":{"tag":"盘后","latestPrice":2.11,"preClose":2.03,"latestTime":"19:43 EDT","volume":719,"amount":1515.0288,"timestamp":1716594232769},"delay":0,"floatShares":1654000,"shares":1656235,"eps":-39.79832,"marketStatus":"美国阵亡战士纪念日休市","marketStatusCode":7,"change":0.02,"latestTime":"05-24 16:00:00 EDT","open":2.01,"high":2.1,"low":2,"amount":155470.09445,"amplitude":0.049751,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-39.79832,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716883200000},"adr":0,"adjPreClose":2.01,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.1086,"preClose":2.01,"latestTime":"09:01 EDT","volume":686,"amount":1447.15521,"timestamp":1716555668049},"postHourTrading":{"tag":"盘后","latestPrice":2.11,"preClose":2.03,"latestTime":"19:43 EDT","volume":719,"amount":1515.0288,"timestamp":1716594232769},"volumeRatio":1.3561537353035567},"requestUrl":"/m/hq/s/BPTH/wiki","defaultTab":"wiki","newsList":[{"id":"2437296092","title":"Bio-Path Holdings, Inc.股价上涨10.00% 市值涨13.78万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437296092","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2437296092?lang=zh_cn&edition=full","pubTime":"2024-05-22 21:59","pubTimestamp":1716386371,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日21时59分，Bio-Path Holdings, Inc.股票出现波动，股价急速上涨10.00%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Mustang Bio, Inc.涨幅较大，Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Coeptis Therapeutics Holdings, Inc.较为活跃，换手率分别为242.47%、118.30%、35.62%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Mustang Bio, Inc.、Rezolute, Inc.，振幅分别为41.87%、35.42%、22.33%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405222159319680f135&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405222159319680f135&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2436819814","title":"Bio-Path Holdings, Inc.2024财年第一财季实现净利润-3.16百万美元，同比增加40.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436819814","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2436819814?lang=zh_cn&edition=full","pubTime":"2024-05-20 00:13","pubTimestamp":1716135218,"startTime":"0","endTime":"0","summary":"3月31日，Bio-Path Holdings, Inc.公布财报，公告显示公司2024财年第一财季净利润为-3.16百万美元，同比增加40.04%；其中营业收入为0.00美元，每股基本收益为-4.88美元。机构评级：截至2024年3月31日，当前有1家机构对Bio-Path Holdings, Inc.目标价做出预测，其中目标均价为20.00美元，其中最低目标价为20.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405200013428b186625&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405200013428b186625&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433472553","title":"Bio Path Holdings Inc    预计每股亏损 4.54 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433472553","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433472553?lang=zh_cn&edition=full","pubTime":"2024-05-08 20:52","pubTimestamp":1715172731,"startTime":"0","endTime":"0","summary":"   * Bio Path Holdings Inc    将于5月15日公布截至2024年3月31日的财报，预计季度营收将保持不变。*    * LSEG 的分析师平均预计 Bio Path Holdings Inc 每股亏损 5.40 美元。* 分析师对该公司股票的评级为 \"买入\"。* 华尔街对 Bio Path Holdings Inc 的 12 个月目标价中值为 40.00 美元，高于其上一次收盘价 3.00 美元。5月8日 - 本摘要于北京时间 5 月 8 日 12:52 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432980588","title":"Bio-Path Holdings, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432980588","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432980588?lang=zh_cn&edition=full","pubTime":"2024-05-03 00:42","pubTimestamp":1714668121,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日00时42分，Bio-Path Holdings, Inc.股票出现异动，股价急速下跌5.01%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Effector Therapeutics Inc C/Wts 31/12/2025 、Sensei Biotherapeutics, Inc.涨幅较大，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃，换手率分别为4226.65%、657.45%、152.19%，振幅较大的相关个股有Allarity Therapeutics, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Ys Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为153.28%、78.82%、49.56%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050300420187e855dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050300420187e855dd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432505513","title":"Bio-Path Holdings, Inc.盘中异动 早盘股价大跌5.81%报2.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432505513","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432505513?lang=zh_cn&edition=full","pubTime":"2024-05-01 22:12","pubTimestamp":1714572773,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日22时12分，Bio-Path Holdings, Inc.股票出现波动，股价快速下跌5.81%。截至发稿，该股报2.67美元/股，成交量1.785万股，换手率1.14%，振幅3.39%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012212537925a1c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012212537925a1c7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431899863","title":"Bio-Path Holdings, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431899863","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431899863?lang=zh_cn&edition=full","pubTime":"2024-04-29 23:26","pubTimestamp":1714404362,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日23时26分，Bio-Path Holdings, Inc.股票出现异动，股价大幅拉升5.04%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Zura Bio Limited C/Wts 、Soleno Therapeutics, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为950.49%、44.50%、21.07%，振幅较大的相关个股有Annovis Bio, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Ginkgo Bioworks Holdings, Inc.，振幅分别为68.35%、33.33%、31.39%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429232603861ea221&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429232603861ea221&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430894482","title":"Bio-Path Holdings, Inc.盘中异动 股价大跌5.20%报2.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430894482","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430894482?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:57","pubTimestamp":1714053460,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时57分，Bio-Path Holdings, Inc.股票出现波动，股价快速下挫5.20%。截至发稿，该股报2.36美元/股，成交量2.3705万股，换手率1.51%，振幅4.82%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为1.47%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425215740792377d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425215740792377d4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429695921","title":"Bio-Path Holdings, Inc.盘中异动 早盘股价大跌12.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429695921","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429695921?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:32","pubTimestamp":1713792727,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日21时32分，Bio-Path Holdings, Inc.股票出现异动，股价快速下跌12.12%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。消息层面，截至21时32分，《Roth MKM：重申Bio-Path Hldgs评级，由买入调整至买入评级, 目标价40.00美元。》资讯为影响Bio-Path Holdings, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222132078b464ee4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222132078b464ee4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428540916","title":"Bio-Path Holdings, Inc.盘中异动 早盘急速跳水6.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428540916","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428540916?lang=zh_cn&edition=full","pubTime":"2024-04-19 21:31","pubTimestamp":1713533485,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日21时31分，Bio-Path Holdings, Inc.股票出现波动，股价急速跳水6.66%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。消息层面，截至21时31分，《Roth MKM：重申Bio-Path Hldgs评级，由买入调整至买入评级, 目标价40.00美元。》资讯为影响Bio-Path Holdings, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419213125861e7730&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419213125861e7730&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428055341","title":"Bio-Path Holdings, Inc.盘中异动 早盘股价大涨9.73%报3.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428055341","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428055341?lang=zh_cn&edition=full","pubTime":"2024-04-17 22:30","pubTimestamp":1713364215,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日22时30分，Bio-Path Holdings, Inc.股票出现异动，股价大幅上涨9.73%。截至发稿，该股报3.35美元/股，成交量1.7751万股，换手率2.35%，振幅6.76%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417223016861e6bc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417223016861e6bc3&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biopathholdings.com","stockEarnings":[{"period":"1week","weight":-0.0514},{"period":"1month","weight":-0.1847},{"period":"3month","weight":-0.653},{"period":"6month","weight":-0.7899},{"period":"1year","weight":-0.9358},{"period":"ytd","weight":-0.7808}],"compareEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0475},{"period":"3month","weight":0.0425},{"period":"6month","weight":0.1628},{"period":"1year","weight":0.2768},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bio-path Holdings, Inc.正处于发展阶段，其领先的治癌药物Liposomal Grb-2目前处于临床试验阶段。该公司在得克萨斯大学的附属医院安德森癌症研究中心的技术支持下成立，在特许协议下致力于研发新的抗癌药物。其拥有用于系统反义疗法的药物传输平台技术与知识产权。该公司还计划研究脂质体肿瘤定位技术，因为这一技术可以完善目前的传输技术，能进一步提高反义疗法的有效性。除了现有的技术专利，该公司将保持与安德森研究中心主要成员的紧密合作关系，因为后者将来可能为该公司提供潜在药物。该公司还希望将其技术扩展到反义药物之外的抗癌药物，包括安德森研究中心之外的机构所提供的候选药物。该公司成立于2007年5月10日。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.055835},{"month":2,"riseRate":0.4,"avgChangeRate":0.01406},{"month":3,"riseRate":0.6,"avgChangeRate":0.683886},{"month":4,"riseRate":0.181818,"avgChangeRate":-0.127567},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.05449},{"month":6,"riseRate":0.6,"avgChangeRate":0.0185},{"month":7,"riseRate":0.3,"avgChangeRate":-0.095426},{"month":8,"riseRate":0.3,"avgChangeRate":-0.14864},{"month":9,"riseRate":0.2,"avgChangeRate":-0.092335},{"month":10,"riseRate":0.6,"avgChangeRate":0.094767},{"month":11,"riseRate":0.4,"avgChangeRate":-0.112549},{"month":12,"riseRate":0.4,"avgChangeRate":-0.110282}],"exchange":"NASDAQ","name":"Bio-Path Holdings, Inc.","nameEN":"Bio-Path"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Bio-Path Holdings, Inc.(BPTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Bio-Path Holdings, Inc.,BPTH,Bio-Path Holdings, Inc.股票,Bio-Path Holdings, Inc.股票老虎,Bio-Path Holdings, Inc.股票老虎国际,Bio-Path Holdings, Inc.行情,Bio-Path Holdings, Inc.股票行情,Bio-Path Holdings, Inc.股价,Bio-Path Holdings, Inc.股市,Bio-Path Holdings, Inc.股票价格,Bio-Path Holdings, Inc.股票交易,Bio-Path Holdings, Inc.股票购买,Bio-Path Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Bio-Path Holdings, Inc.(BPTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况